Advance Search
ZHAI Yun, ZHAO Yaling. Effect of losartan combined with spironolactone in the treatment of coronary artery microembolization[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 94-96. DOI: 10.7619/jcmp.202002027
Citation: ZHAI Yun, ZHAO Yaling. Effect of losartan combined with spironolactone in the treatment of coronary artery microembolization[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 94-96. DOI: 10.7619/jcmp.202002027
shu

Effect of losartan combined with spironolactone in the treatment of coronary artery microembolization

  • Department of Geriatrics, Xi'an Labor Union Hospital, Xi'an, Shaanxi, 710100

More Information
  • Received Date: November 12, 2019
  • Available Online: August 26, 2020
  • Published Date: August 26, 2020
    Graphical Abstract
    • Abstract
  • Objevtive To analyze the efficacy of losartan combined with spironolactone in the treatment of coronary artery microembolization and its effects on levels of serum matrix metalloproteinase-9(MMP-9), tissue inhibitor of metalloproteinase-1(TIMP-1), high sensitivity C reactive protein(hs-CRP). Methods Sixty-four patients with coronary artery microembolism admitted to our hospital were randomly divided into two groups. The control group(n=32)was treated with losartan, and the experimental group(n=32)was treated with lozafloxacin and spironolactone. The clinical efficacy, cardiac function indicators, serum MMP-9, TIMP-1, hs-CRP levels were compared. Results The total clinical effective rate in the experimental group was significantly higher than that in the control group(93.75% vs. 65.62%, P<0.05). After treatment, the experimental group had significantly lower results in left ventricular end-diastolic diameter(LVEDD), left ventricular end systolic diameter(LVESD), MMP-9, TIMP-1, hs-CRP levels than the control group, and left ventricular ejection fraction(LVEF)was significantly higher than that in the control group(P<0.05). Conclusion Losartan combined with spironolactone can effectively improve the clinical symptoms of patients with coronary artery microembolism, inhibit level of inflammatory factors such as hs-CRP, and improve the heart function.
    • FullText(HTML)
    • References (16)
  • 张万壮, 张瑞凤, 李俊芹, 等. Embosphere微球在动脉栓塞治疗支气管扩张大咯血中的应用[J]. 中国煤炭工业医学杂志, 2017, 20(8): 910-913.

    Wollina U, Koch A, Heinig B, et al. Cutaneous microembolism of fingers and toes[J]. Open Access Maced J Med Sci, 2018, 6(1): 166-169.
    苏强, 李浪, 孙羽涵, 等. 尼可地尔预处理对冠状动脉微栓塞PDCD4/NF-κB/TNF-α通路的影响及意义[J]. 中华急诊医学杂志, 2018, 27(10): 1083-1088.
    中华医学会心血管病学分会基础研究学组, 中华医学会心血管病学分会介入心脏病学组, 中华医学会心血管病学分会女性心脏健康学组, 等. 冠状动脉微血管疾病诊断和治疗的中国专家共识[J]. 中国循环杂志, 2017, 32(5): 421-430.
    谢亮, 何松清, 刘晶, 等. 心房颤动继发冠状动脉栓塞致急性下壁心肌梗死1例[J]. 江苏医药, 2017, 43(15): 1129-1130.
    朱慧敏, 郭军. 冠状动脉非阻塞性心肌梗死的的诊断及治疗进展[J]. 中国循证心血管医学杂志, 2017, 9(1): 122-123.
    卜军, 王奇雯, 叶豪, 等. 心肌梗死后冠状动脉微循环障碍机制与干预[J]. 内科理论与实践, 2017, 12(1): 15-20.
    Yang W X, Lai C L, Chen F H, et al. The value of Sonoclot detection technology to guide the clinical medication of the perioperative anticoagulation and antiplatelet therapy in patients with acute myocardial infarction undergoing emergent PCI[J]. Exp Ther Med, 2017, 13(6): 2917-2921.
    曹乾, 赵春艳, 史瑾, 等. 冠状动脉内注射肾上腺素对急性心肌梗死患者经皮冠状动脉介入治疗术中慢血流的疗效[J]. 中华危重病急救医学, 2016(7): 643-645.
    姜楠, 谭团团, 高顺记, 等. 低强度聚焦超声联合全氟戊烷相变纳米粒治疗冠状动脉血栓栓塞的体外溶栓效率及安全性研究[J]. 临床超声医学杂志, 2019, 21(5): 321-326.
    陈翔, 朱嘉琦, 郑兴. Glubran-2胶栓塞治疗冠状动脉穿孔[J]. 国际心血管病杂志, 2016, 43(5): 313-314.
    匡雄伟, 刘振生, 孙勇, 等. 钳夹取栓治疗心源性脑栓塞的效果研究[J]. 实用临床医药杂志, 2018, 22(9): 27-30

    , 35.
    王保平, 孙余华. 冠状动脉微血管功能障碍和微血管心绞痛[J]. 临床心血管病杂志, 2018, 34(10): 957-960.
    魏海亮, 李翠君, 刘吉祥, 等. 双微导管技术血管内栓塞治疗的临床效果及对患者认知功能的影响[J]. 河北医科大学学报, 2017, 38(9): 1029-1032.
    吴珂. 血压正常伴右心功能不全的急性肺栓塞患者远期预后的危险因素分析[J]. 实用临床医药杂志, 2017, 21(3): 179-180

    , 187.
    Zachura M, Sadowski M, Janion-Sadowska A, et al. Acute myocardial infarction due to coronary embolism originating from left ventricle thrombus in a patient with dilated cardiomyopathy and sinus rhythm[J]. Advances in Interventional Cardiology, 2016, 12(1): 73-74.
    • Related Articles

  • Cited by

    Periodical cited type(14)

    1. 张华朋，章赛玉，陈华永. 七氟烷对冠心病颅脑手术患者行控制性降血压的脑保护效果. 中国当代医药. 2021(09): 117-120 .
    2. 杜力侠，沈如刚. 静吸复合麻醉与全凭静脉麻醉在急性创伤性颅脑损伤患者治疗中的效果分析. 系统医学. 2021(19): 4-7 .
    3. 张娇娇，薛志强，刘丽霞. 异丙酚联合地氟烷麻醉对颅脑损伤患者的脑保护作用研究. 湖南师范大学学报(医学版). 2020(01): 142-145 .
    4. 郝维强，魏宏姗. 重型颅脑损伤丙泊酚麻醉临床分析. 中国继续医学教育. 2020(06): 70-73 .
    5. 汪金娇，李海中，刘彦锋. 丙泊酚全身麻醉对颅脑外伤急诊手术患者神经损伤程度及氧化应激影响. 社区医学杂志. 2020(11): 792-795 .
    6. 张志伟，孙荣青. 右美托咪定联合瑞芬太尼在重型颅脑损伤术后镇痛镇静效果. 内蒙古医学杂志. 2020(08): 959-960 .
    7. 李军根，陆士奇，肖接承，丁礼. 全凭静脉麻醉与静吸复合麻醉对重症颅脑创伤患者血流动力学及IL-6、ADR、NADR水平的影响. 现代医学与健康研究电子杂志. 2020(15): 72-74 .
    8. 王安平，岳新霞，海力茜·陶尔大洪，陈新，罗庆元. 丙泊酚对重型颅脑损伤手术患者血流动力学、术后镇痛镇静效果及血清hs-CRP、PCT、IL-22表达的影响. 解放军医药杂志. 2019(02): 107-112 .
    9. 潘明，贾衍杰. 丙泊酚静脉麻醉在急性重型颅脑损伤手术患者中的应用效果. 中国当代医药. 2019(02): 183-185 .
    10. 王仕斌，王雪婷，薛荣亮，陈蓉，路丕周，刘世明. 异丙酚联合地氟烷麻醉对颅脑损伤患者脑保护及脑供氧平衡的影响. 现代生物医学进展. 2019(24): 4793-4796 .
    11. 陈艳霞. 瑞芬太尼复合丙泊酚对重型颅脑损伤患者脑氧代谢及炎症因子的影响. 临床研究. 2018(11): 36-38 .
    12. 吴悠扬，周春丽，王勇. 丙泊酚复合瑞芬太尼靶控输注联合灯盏细辛注射液对脑胶质瘤切除术患者脑保护及苏醒质量的影响. 现代中西医结合杂志. 2018(29): 3290-3293 .
    13. 田佩松. 颅脑损伤手术中全凭静脉麻醉与静吸复合麻醉的应用效果对比. 实用医技杂志. 2018(12): 1385-1387 .
    14. 许镇. 右美托咪定与丙泊酚对重症颅脑损伤患者脑代谢及预后的影响比较. 中外医学研究. 2018(31): 148-149 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (616) PDF downloads (21) Cited by(14)
    Turn off MathJax
    Article Contents
    Abstract
    References

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return